International_Longevity_Alliance

International Longevity Alliance

International Longevity Alliance

International nonprofit organization


The International Longevity Alliance (ILA) is an international nonprofit organization that is a platform for interaction between regional organizations that support anti-aging technologies, usually at the administrative and popularization levels.

Quick Facts Abbreviation, Formation ...

Purpose

The declared objectives of the organization are to establish regional organizations' interaction and collaboration, to popularize the idea of the need to combat the aging process as a negative but treatable medical condition of the body, and to provide support for scientific research in all possible ways and at all possible levels around the world (up to cooperation with WHO).[3][4]

History

ILA began to function in January 2013 as an informal platform for communication between managers and representatives of several organizations.[5] In September 2014, the alliance was formally registered in Paris, France, acquiring the status of an official organization.[6]

Organizations

As of April 2024, ILA includes 55 nonprofit organizations from 33 countries.[1] Some of them are:

Moreover, the ILA's Board of Advisors includes Aubrey de Grey, Alexey Moskalev [ru], Natasha Vita-More, and others.[12]

Activity

In addition to being a platform for interaction between organizations and facilitating their activities, the alliance also periodically holds online conferences, seminars and other public events to draw people's attention to the problem of aging.[13][14][15][16][17] ILA popularize the initiative of holding the International Longevity Day (October 1) and the International Longevity Month (October) to promote biomedical aging research.[18][19][20][21][22] Another anniversary date that the organization popularizes and promotes is the Metchnikoff Day,[23][24][25][26][27][13] which falls on May 15 – the birthday of Élie Metchnikoff, who is considered the founder of gerontology.[28][29]

Permanently-supported projects:

  • Major Mouse Testing Program (MMTP) – project aimed at testing potential anti-aging approaches in mice.[30][31]
  • DENIGMA – IT-platform of computational biology of aging.[32]
  • Longevity for All – public information resource.
  • Longevity History – educational resource on the history of the study of aging.(see External links)

ILA attaches particular importance to cooperation with WHO in order to draw the attention of the state and interstate structures to the problem of aging as a type of medical problem that needs scientific study and treatment.[33][34][35][36][37][38] In particular, ILA took an active part in the discussion, as a result of which WHO included in the international classification of diseases ICD-11 a special additional code XT9T. Now, after that, aging began to be officially recognized as a major factor that increases the risk of diseases, the severity of their course and the difficulty of treatment.[39][40][41]

Critique

ILA does not have an official office – ILA members are located in different countries around the world and in the vast majority of cases communicate with each other only via the Internet. ILA conferences are also usually online. ILA does not have its own scientific laboratories, always acting only as a partner organization and/or providing administrative and public support.

See also


References

  1. "Federated members of the International Longevity Alliance". ILA. Retrieved 24 April 2024.
  2. "Board of Directors". ILA. Archived from the original on 2021-05-11. Retrieved 2021-05-12.
  3. "Manifesto". ILA. Retrieved 2021-05-12.
  4. "International Longevity Alliance". Live Forever Club. Retrieved 2021-05-12.
  5. "ILA History". ILA. Retrieved 2021-05-12.
  6. "Israeli Longevity Alliance – ISRLA – VETEK". Israeli Longevity Alliance. Retrieved 2021-05-12.
  7. "Our Coalition". Global Healthspan Policy Institute. Retrieved 2021-05-12.
  8. "Наши партнеры" [Our partners]. Council for Public Health and the Problems of Demography (in Russian). Archived from the original on 2021-05-11. Retrieved 2021-05-12.
  9. "Supporting Organisations". Institute of Exponential Sciences. Retrieved 2021-05-12.
  10. "Board of Advisors". ILA. Archived from the original on 2021-05-12. Retrieved 2021-05-12.
  11. ILA (2020-05-16). "ILA Conference - Metchnikoff Day" (video). YouTube.
  12. Ilia Stambler; Alexey Moskalev. "Clinical Evaluation Criteria for Aging and Aging-related Multimorbidity". Frontiers Research Topic. Retrieved 2021-05-12.
  13. Stambler, Ilia; Milova, Elena (2019-05-08). "Longevity Activism". In Gu, Danan; Dupre, Matthew E. (eds.). Encyclopedia of Gerontology and Population Aging. pp. 1–7. doi:10.1007/978-3-319-69892-2_395-1. ISBN 978-3-319-69892-2. S2CID 239107136.
  14. José Luis Cordeiro (2020-10-03). "Día Internacional de la Longevidad" [The International Longevity Day]. El Universal (in Spanish).
  15. "Longevity activism prize winners announced". Longevity for All. 2020-11-20.
  16. Elena Milova (2017-05-12). "Commemorating the Work of Dr. Elie Metchnikoff". Lifespan.io. Archived from the original on 2021-05-12. Retrieved 2021-05-13.
  17. Harris, D.K. (1988). Dictionary of Gerontology. New York: Greenwood Press. p. 80. ISBN 978-0-313-25287-7.
  18. Khaltourina, Daria; Matveyev, Yuri; Alekseev, Aleksey; Cortese, Franco; Ioviţă, Anca (July 2020). "Aging Fits the Disease Criteria of the International Classification of Diseases". Mechanisms of Ageing and Development. 189: 111230. doi:10.1016/j.mad.2020.111230. PMID 32251691. S2CID 214779653.
  19. The Lancet Diabetes & Endocrinology (1 August 2018). "Opening the door to treating ageing as a disease". The Lancet Diabetes & Endocrinology. 6 (8): 587. doi:10.1016/S2213-8587(18)30214-6. PMID 30053981. S2CID 51726070.

Share this article:

This article uses material from the Wikipedia article International_Longevity_Alliance, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.